Search research articles
Contact Us
Filters
Showing results (11-20 of 218) with videos related to
Page
of 22
Sort By:
Clinical Endocrinology
|
May 1, 2007
Can cortisol predict the future in obesity?
Rebecca M Reynolds, Brian R Walker
Endocrine
|
April 20, 2006
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity
Deborah J Wake, Brian R Walker
Diabetes, Obesity & Metabolism
|
January 25, 2003
Human insulin resistance: the role of glucocorticoids
Rebecca M Reynolds, Brian R Walker
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats
Dawn E W Livingstone, Brian R Walker
Stress (Amsterdam, Netherlands)
|
November 21, 2015
Systematic review and meta-analysis reveals acutely elevated plasma cortisol following fasting but not less severe calorie restriction
Yuko Nakamura, Brian R Walker, Toshikazu Ikuta
The Journal of Endocrinology
|
April 25, 2008
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
David P Macfarlane, Shareen Forbes, Brian R Walker
The Journal of Clinical Endocrinology and Metabolism
|
January 10, 2003
Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes
Robert C Andrews, Olav Rooyackers, Brian R Walker
Annals of Internal Medicine
|
November 17, 2004
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
Li Wei, Thomas M MacDonald, Brian R Walker
Diabetologia
|
April 9, 2014
Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
Andreas Stomby, Ruth Andrew, Brian R Walker, et al.
The New England Journal of Medicine
|
August 2, 2013
Reduced cortisol metabolism during critical illness
Greet Van den Berghe, Eva Boonen, Brian R Walker
Page
of 22
Search research articles
Search
Showing results (11-20 of 218) with videos related to
Sort By:
Page
of 22
Clinical Endocrinology
|
May 1, 2007
Can cortisol predict the future in obesity?
Rebecca M Reynolds, Brian R Walker
Endocrine
|
April 20, 2006
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity
Deborah J Wake, Brian R Walker
Diabetes, Obesity & Metabolism
|
January 25, 2003
Human insulin resistance: the role of glucocorticoids
Rebecca M Reynolds, Brian R Walker
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats
Dawn E W Livingstone, Brian R Walker
Stress (Amsterdam, Netherlands)
|
November 21, 2015
Systematic review and meta-analysis reveals acutely elevated plasma cortisol following fasting but not less severe calorie restriction
Yuko Nakamura, Brian R Walker, Toshikazu Ikuta
The Journal of Endocrinology
|
April 25, 2008
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
David P Macfarlane, Shareen Forbes, Brian R Walker
The Journal of Clinical Endocrinology and Metabolism
|
January 10, 2003
Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes
Robert C Andrews, Olav Rooyackers, Brian R Walker
Annals of Internal Medicine
|
November 17, 2004
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
Li Wei, Thomas M MacDonald, Brian R Walker
Diabetologia
|
April 9, 2014
Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
Andreas Stomby, Ruth Andrew, Brian R Walker, et al.
The New England Journal of Medicine
|
August 2, 2013
Reduced cortisol metabolism during critical illness
Greet Van den Berghe, Eva Boonen, Brian R Walker
Page
of 22